Total Payments
$8,003
2024 Payments
$1,666
Companies
59
Transactions
370
Medicare Patients
14,686
Medicare Billing
$823,143
Payment Breakdown by Category
Food & Beverage$7,843 (98.0%)
Education$159.67 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,843 | 359 | 98.0% |
| Education | $159.67 | 3 | 2.0% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
General
$8,003
362 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,177 | 65 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $747.48 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $590.91 | 34 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $572.91 | 17 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $359.92 | 12 | $0 (2024) |
| PFIZER INC. | $311.50 | 25 | $0 (2024) |
| Allergan, Inc. | $296.64 | 11 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $294.48 | 14 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $290.34 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $258.88 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,666 | 69 | Astellas Pharma US Inc ($223.49) |
| 2023 | $1,483 | 53 | Myriad Genetic Laboratories, Inc. ($547.99) |
| 2022 | $808.31 | 37 | Endo Pharmaceuticals Inc. ($91.24) |
| 2021 | $788.66 | 43 | Astellas Pharma US Inc ($197.95) |
| 2020 | $547.72 | 33 | Astellas Pharma US Inc ($190.97) |
| 2019 | $1,280 | 55 | Astellas Pharma US Inc ($234.72) |
| 2018 | $744.96 | 41 | Astellas Pharma US Inc ($201.34) |
| 2017 | $683.96 | 39 | Endo Pharmaceuticals Inc. ($171.94) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $77.97 | General |
| 12/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.99 | General |
| 12/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: HORMONE THERAPY | ||||||
| 11/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $37.63 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | LSI SOLUTIONS INC | JNW URTRAC (Device), RUNNING DEVICE, Ti-KNOT | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NONE | ||||||
| 09/10/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: UROLOGY | ||||||
| 08/29/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $60.29 | General |
| 08/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,789 | 5,315 | $763,721 | $228,610 |
| 2022 | 21 | 3,604 | 5,051 | $660,824 | $189,410 |
| 2021 | 25 | 3,934 | 5,462 | $772,757 | $227,016 |
| 2020 | 22 | 3,359 | 4,473 | $594,291 | $178,107 |
Total Patients
14,686
Total Services
20,301
Medicare Billing
$823,143
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 754 | 999 | $319,680 | $92,332 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 354 | 391 | $88,757 | $24,344 | 27.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 97 | 114 | $69,540 | $21,027 | 30.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 94 | 389 | $61,851 | $18,950 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 121 | 121 | $51,062 | $14,692 | 28.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 96 | $32,256 | $12,857 | 39.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 753 | 1,052 | $27,352 | $8,057 | 29.5% |
| 52353 | Crushing of stone of ureter using an endoscope | Facility | 2023 | 22 | 22 | $22,022 | $6,813 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 47 | $16,027 | $4,967 | 31.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 74 | $13,246 | $4,740 | 35.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 889 | 1,236 | $8,652 | $3,835 | 44.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 337 | 407 | $2,442 | $2,393 | 98.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 68 | 75 | $14,475 | $2,226 | 15.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 26 | 49 | $7,644 | $2,128 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $6,149 | $1,943 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,902 | $1,860 | 31.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 17 | 17 | $5,661 | $1,795 | 31.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 41 | $3,321 | $1,056 | 31.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 14 | $3,584 | $952.42 | 26.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 21 | $2,058 | $852.39 | 41.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 16 | 16 | $1,040 | $411.04 | 39.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 58 | 95 | $475.00 | $209.00 | 44.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 15 | $525.00 | $167.25 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 671 | 854 | $274,764 | $76,528 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 454 | 531 | $120,791 | $32,322 | 26.8% |
About Dr. Stephen Weiss, MD
Dr. Stephen Weiss, MD is a Urology healthcare provider based in Deland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073564910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Weiss, MD has received a total of $8,003 in payments from pharmaceutical and medical device companies, with $1,666 received in 2024. These payments were reported across 370 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($7,843).
As a Medicare-enrolled provider, Weiss has provided services to 14,686 Medicare beneficiaries, totaling 20,301 services with total Medicare billing of $823,143. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Deland, FL
- Active Since 05/15/2006
- Last Updated 09/25/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1073564910
Products in Payments
- PROLARIS (Device) $667.62
- XTANDI (Drug) $550.02
- XIAFLEX (Biological) $378.50
- MYRBETRIQ (Drug) $335.54
- Erleada (Drug) $331.78
- ERLEADA (Drug) $300.00
- PROVENGE (Drug) $290.34
- BOTOX (Biological) $265.39
- AVEED (Biological) $241.51
- Prolia (Biological) $224.30
- ELIGARD (Drug) $217.78
- KEYTRUDA (Biological) $201.54
- ADSTILADRIN (Biological) $200.58
- Xofigo (Drug) $190.93
- INTERSTIM (Device) $171.71
- Nubeqa (Drug) $168.99
- ORGOVYX (Drug) $149.05
- REZUM (Device) $148.21
- BOTOX OAB (Drug) $125.01
- Cook Medical Holmium Laser Fiber (Device) $105.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.